\-\ Texto\\:\\ \ \(0\)\
\-\ bibasilar\\ crackles\ \(4\)\
\-\ this\\ case\\:\\ treated\\ with\\ corticosteroid\\ therapy\\ with\\ improvement\\ of\\ symptoms\\ and\\ ct\\ findings\\.\ \(0\)\
\-\ in\\ general\\:\\ \\ removal\\ from\\ antigen\\ exposure\\ \\+\\/\\-\\ corticosteroid\\ treatment\\.\ \(0\)\
\-\ cxr\\:\\ bibasilar\\ linear\\ interstitial\\ pattern\ \(0\)\
\-\ ct\\ \\(pe\\ study\\)\\:\\ diffuse\\ ground\\ glass\\ greater\\ at\\ bases\ \(0\)\
\-\ extrinsic\\ allergic\\ alveolitis\\ \\(hypersensitivity\\ pneumonitis\\)\\-acute\ \(0\)\
\-\ 1\\)hypersensitivity\\ pneumonitis\ \(0\)\
\-\ 2\\)acute\\ interstitial\\ disease\\ \\(dip\\,\\ aip\\,\\ viral\\)\ \(0\)\
\-\ 3\\)eosinophilic\\ pneumonia\ \(0\)\
\-\ 4\\)pulmonary\\ edema\ \(0\)\
\-\ 34\\ y\\/o\\ male\\ with\\ cough\\ and\\ dyspnea\\.\\ \\ no\\ specific\\ exposures\\.\ \(0\)\
\-\ chest\\ x\\-ray\\ findings\\:\ \(1\)\
\-\ acute\\:\\ diffuse\\ micronodular\\ interstitial\\ pattern\\.\\ \\ \\(\\+\\/\\-\\ ground\\-glass\\ density\\ in\\ the\\ lower\\ and\\ middle\\ lung\\ zones\\)\\.\\ \\ normal\\ in\\ 10\\%\\.\\ \ \(0\)\
\-\ subacute\\:\\ micronodular\\ or\\ reticular\\ opacities\\ are\\ most\\ prominent\\ in\\ mid\\-to\\-upper\\ lung\\ zones\\.\ \(0\)\
\-\ chronic\\:\\ progressive\\ fibrotic\\ changes\\ with\\ loss\\ of\\ lung\\ volume\\ particularly\\ affect\\ the\\ upper\\ lobes\\.\\ nodular\\ or\\ ground\\-glass\\ opacities\\ are\\ not\\ features\\.\\ \ \(0\)\
\-\ \\	\ \(2191\)\
\-\ hrct\\ findings\\:\ \(0\)\
\-\ acute\\:\\ ground\\-glass\\ or\\ diffusely\\ increased\\ opacities\\.\\ \ \(0\)\
\-\ subacute\\:\\ \\ diffuse\\ micronodules\\,\\ ground\\-glass\\,\\ focal\\ air\\ trapping\\,\\ and\\ mild\\ fibrotic\\ changes\\.\ \(0\)\
\-\ chronic\\:\\ \\ may\\ see\\ mixture\\ of\\ ground\\ glass\\,\\ air\\ trapping\\,\\ cystic\\ changes\\ with\\ fibrotic\\ changes\\.\ \(0\)\
\-\ diagnosis\\:\\ \\ combination\\ of\\ clinical\\,\\ radiographic\\,\\ pft\\'s\\,\\ and\\ bronchioalveolar\\ lavage\\ can\\ suggest\\ diagnosis\\.\\ \\ biopsy\\ may\\ be\\ needed\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ glass\\:\\ 0\\.3939760176748164\ \(0\)\
\-\ ground\\:\\ 0\\.3812642655225564\ \(0\)\
\-\ fibrotic\\:\\ 0\\.24178644980063405\ \(0\)\
\-\ opacities\\:\\ 0\\.18696682487257782\ \(0\)\
\-\ micronodular\\:\\ 0\\.1836386538931776\ \(0\)\
\-\ interstitial\\:\\ 0\\.17752812460781484\ \(0\)\
\-\ changes\\:\\ 0\\.15780105429674265\ \(0\)\
\-\ zones\\:\\ 0\\.1539026951321437\ \(0\)\
\-\ hypersensitivity\\:\\ 0\\.15097704466959536\ \(0\)\
\-\ pneumonitis\\:\\ 0\\.15097704466959536\ \(0\)\
\-\ trapping\\:\\ 0\\.14838335480072737\ \(0\)\
\-\ bibasilar\\:\\ 0\\.1475802395044267\ \(0\)\
\-\ corticosteroid\\:\\ 0\\.1475802395044267\ \(0\)\
\-\ acute\\:\\ 0\\.14124789443153582\ \(0\)\
\-\ diffuse\\:\\ 0\\.12280892780459991\ \(0\)\
\-\ subacute\\:\\ 0\\.12217535593320125\ \(0\)\
\-\ lung\\:\\ 0\\.1191249528095737\ \(0\)\
\-\ aip\\:\\ 0\\.10439098766608483\ \(0\)\
\-\ pft\\:\\ 0\\.10439098766608483\ \(0\)\
\-\ micronodules\\:\\ 0\\.0997511617463244\ \(0\)\
\-\ pattern\\:\\ 0\\.09746964701347881\ \(0\)\
\-\ findings\\:\\ 0\\.09664939214589237\ \(0\)\
\-\ bronchioalveolar\\:\\ 0\\.09645915286634922\ \(0\)\
\-\ alveolitis\\:\\ 0\\.09005534699983489\ \(0\)\
\-\ exposures\\:\\ 0\\.09005534699983489\ \(0\)\
\-\ air\\:\\ 0\\.08539312963001729\ \(0\)\
\-\ hrct\\:\\ 0\\.08488318236580746\ \(0\)\
\-\ lavage\\:\\ 0\\.08133401168081301\ \(0\)\
\-\ antigen\\:\\ 0\\.07990174245896482\ \(0\)\
\-\ chronic\\:\\ 0\\.07749227220277896\ \(0\)\
\-\ mixture\\:\\ 0\\.07748368628033886\ \(0\)\
\-\ dip\\:\\ 0\\.07595565734711758\ \(0\)\
\-\ allergic\\:\\ 0\\.07460784030733232\ \(0\)\
\-\ reticular\\:\\ 0\\.07460784030733232\ \(0\)\
\-\ extrinsic\\:\\ 0\\.07039988521564906\ \(0\)\
\-\ upper\\:\\ 0\\.06976526971502588\ \(0\)\
\-\ or\\:\\ 0\\.06812536986478954\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0676775251875449\ \(0\)\
\-\ affect\\:\\ 0\\.06755668753506207\ \(0\)\
\-\ and\\:\\ 0\\.06744272383450463\ \(0\)\
\-\ crackles\\:\\ 0\\.06733008173946878\ \(0\)\
\-\ bases\\:\\ 0\\.06710787633567389\ \(0\)\
\-\ may\\:\\ 0\\.06569816809504632\ \(0\)\
\-\ in\\:\\ 0\\.06495448319250757\ \(0\)\
\-\ with\\:\\ 0\\.06390956171002699\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.0635440442537594\ \(0\)\
\-\ exposure\\:\\ 0\\.06203617958783628\ \(0\)\
\-\ particularly\\:\\ 0\\.06162001668086763\ \(0\)\
\-\ diffusely\\:\\ 0\\.06070407046915955\ \(0\)\
\-\ combination\\:\\ 0\\.06057900672453614\ \(0\)\
\-\ viral\\:\\ 0\\.06021181312242287\ \(0\)\
\-\ dyspnea\\:\\ 0\\.057443542265794456\ \(0\)\
\-\ volume\\:\\ 0\\.05734935886391223\ \(0\)\
\-\ improvement\\:\\ 0\\.05698019076110721\ \(0\)\
\-\ 34\\:\\ 0\\.05688973006290163\ \(0\)\
\-\ lobes\\:\\ 0\\.054463095758888413\ \(0\)\
\-\ pe\\:\\ 0\\.053963935434726246\ \(0\)\
\-\ needed\\:\\ 0\\.05389437158080003\ \(0\)\
\-\ suggest\\:\\ 0\\.05302653988453429\ \(0\)\
\-\ linear\\:\\ 0\\.05258514890721357\ \(0\)\
\-\ features\\:\\ 0\\.05252346024714043\ \(0\)\
\-\ general\\:\\ 0\\.0524010717143891\ \(0\)\
\-\ cxr\\:\\ 0\\.052219908795086686\ \(0\)\
\-\ nodular\\:\\ 0\\.051982735150137675\ \(0\)\
\-\ pneumonia\\:\\ 0\\.051522644286227805\ \(0\)\
\-\ prominent\\:\\ 0\\.05141045496868608\ \(0\)\
\-\ of\\:\\ 0\\.05109711885168348\ \(0\)\
\-\ progressive\\:\\ 0\\.04999461535300653\ \(0\)\
\-\ removal\\:\\ 0\\.049896389696417416\ \(0\)\
\-\ ct\\:\\ 0\\.04970258782802889\ \(0\)\
\-\ are\\:\\ 0\\.0495387615203205\ \(0\)\
\-\ specific\\:\\ 0\\.04946451886834025\ \(0\)\
\-\ cough\\:\\ 0\\.048734823506739404\ \(0\)\
\-\ radiographic\\:\\ 0\\.0484296529222131\ \(0\)\
\-\ greater\\:\\ 0\\.04809056978081871\ \(0\)\
\-\ middle\\:\\ 0\\.04667797090112509\ \(0\)\
\-\ biopsy\\:\\ 0\\.04575634708139643\ \(0\)\
\-\ study\\:\\ 0\\.043534577340261955\ \(0\)\
\-\ density\\:\\ 0\\.04328489720842895\ \(0\)\
\-\ clinical\\:\\ 0\\.04136903974535773\ \(0\)\
\-\ treated\\:\\ 0\\.04064938614931609\ \(0\)\
\-\ see\\:\\ 0\\.04060587575951645\ \(0\)\
\-\ pulmonary\\:\\ 0\\.03978890398363744\ \(0\)\
\-\ loss\\:\\ 0\\.03976870412185073\ \(0\)\
\-\ cystic\\:\\ 0\\.03931368474722241\ \(0\)\
\-\ focal\\:\\ 0\\.03904532226039942\ \(0\)\
\-\ edema\\:\\ 0\\.03893220879840085\ \(0\)\
\-\ 10\\:\\ 0\\.03817025515882235\ \(0\)\
\-\ therapy\\:\\ 0\\.03750545837035661\ \(0\)\
\-\ mild\\:\\ 0\\.03700326911031248\ \(0\)\
\-\ symptoms\\:\\ 0\\.035715484523723716\ \(0\)\
\-\ increased\\:\\ 0\\.0352983100615075\ \(0\)\
\-\ chest\\:\\ 0\\.034456130134448856\ \(0\)\
\-\ can\\:\\ 0\\.03425492550074109\ \(0\)\
\-\ most\\:\\ 0\\.03397175448268015\ \(0\)\
\-\ lower\\:\\ 0\\.0333562520753023\ \(0\)\
\-\ case\\:\\ 0\\.0327940949040773\ \(0\)\
\-\ treatment\\:\\ 0\\.03109455740054746\ \(0\)\
\-\ male\\:\\ 0\\.029063512386597812\ \(0\)\
\-\ disease\\:\\ 0\\.027400664766532\ \(0\)\
\-\ normal\\:\\ 0\\.02665186877117173\ \(0\)\
\-\ be\\:\\ 0\\.026479978526286387\ \(0\)\
\-\ the\\:\\ 0\\.026049967561068595\ \(0\)\
\-\ from\\:\\ 0\\.02592497229511734\ \(0\)\
\-\ not\\:\\ 0\\.025769523882237334\ \(0\)\
\-\ at\\:\\ 0\\.024655678574006107\ \(0\)\
\-\ this\\:\\ 0\\.022430106467416906\ \(0\)\
\-\ no\\:\\ 0\\.021227104564311736\ \(0\)\
